- Oops!Something went wrong.Please try again later.
STLD earnings call for the period ending June 30, 2021.
What happened Shares of Novavax (NASDAQ: NVAX) were jumping 9.7% as of 10:48 a.m. EDT on Thursday. There were a couple of catalysts for the stock. Novavax and its partner, Serum Institute of India, announced Thursday morning that they have filed for World Health Organization emergency use listing of Novavax's COVID-19 vaccine.
‘I have made an earnest attempt to get the bank to take their money back, so I was wondering if at any point or time the money would become legally mine.’
In the face of powerful stock market strength, it's important to focus on the long term for the best results.
These stocks are all about the big payoff.
ARK Invest buys more into a pair of sports betting plays and one of its largest holdings that has come under pressure lately.
The House of Representatives will vote on a bill this week that could be a game-changer in terms of how cannabis companies do business in the U.S.
In another "Executive Decision" segment during Wednesday's Mad Money program, Jim Cramer spoke with John Riccitiello, chairman, president and CEO of Unity Software , the engine behind most of the 3D applications available today. Riccitiello explained that Unity provides tools so that developers can build new ways to experience the world. The Unity engine is what powers 70% of all mobile gaming experiences, Riccitiello said.
We are going to take the expected fundamental performance for the company and build a simple discounted cash flow model (valuation), in order to help investors get more clarity on what kind of performance they need to expect from management if they want the stock price to converge with the value of Lucid.
The Ways and Means Committee recently unveiled a batch of proposed tax law changes zeroing in on how the super-rich use retirement accounts
Yahoo Finance Live breaks down which companies are making big moves in the market this morning.
Let's talk about the popular Micron Technology, Inc. ( NASDAQ:MU ). The company's shares received a lot of attention...
Axsome Therapeutics (NASDAQ: AXSM) is close to earning approval for a new depression drug that could generate billions in annual revenues. Unfortunately, the proposed action date for the Food and Drug Administration (FDA) to grant approval already came and went. Consensus price targets suggest Axsome Therapeutics' stock price could rise 197% if most investors begin seeing the company in the same light as the investment-bank analysts who follow it closely.
It’s time to start buying this September pullback in the stock market. Lehman Brothers blew up in 2008 because the U.S. government failed to realize it was too big to fail. Lehman had sold a lot of flawed financial products around the world, so when it blew up, it created systemic problems.
Shares of Carnival (NYSE: CCL) had jumped a solid 3% as of 9:45 a.m. EDT on Thursday after the cruise line announced it is on track to have 50% of its fleet sailing again by October, and 65% by the end of the year. In its press release this morning, Carnival said that by the end of October, it will have resumed operations on 42 ships covering eight of its cruise line brands: Carnival, Princess, Holland America, Seabourn, Costa, AIDA, P&O, and Cunard.
Shares of Rite Aid (NYSE: RAD) were sinking 8% as of 11:06 a.m. EDT on Thursday. The decline came after the pharmacy chain announced its second-quarter earnings results before the market opened. The company announced an adjusted net loss from continuing operations in the second quarter of $22 million, or $0.41 per share.
Cathie Wood believes in the potential of gene editing. It's not surprising that Wood's ARK Genomic Revolution ETF (NYSEMKT: ARKG) and ARK Innovation ETF (NYSEMKT: ARKK) have invested heavily in several gene-editing stocks. The ARK Innovation ETF recently sold some of its shares of Editas Medicine (NASDAQ: EDIT).
Extending the 7% rise that they had been on through the close of yesterday's trading session, shares of Plug Power (NASDAQ: PLUG) are bounding even higher today. Whereas yesterday's climb was attributable to overall enthusiasm for fuel cell solutions, investors are picking up shares today in reaction to news from Wall Street. Taking a more bullish stance on Plug Power's stock, Pearce Hammond, an analyst at Piper Sandler, upgraded the stock to overweight from neutral, keeping the price target at $33.
A provision in the House Ways and Means Committee's recently passed $2.1 trillion package would eliminate the backdoor Roth and mega backdoor Roth IRA conversions.
Yahoo Finance's Anjalee Khemlani gives a Covid-19 update as the CDC advisory committee is set to vote on Pfizer booster data
Chinese Estates, which is controlled by Hong Kong billionaire Joseph Lau and his wife, Chan Hoi-wan, said it had recently pared its stake in Evergrande and it was seeking shareholder approval to potentially sell the remainder.